A Republican senator is about to file a bill that pushes something you don’t hear every day on Capitol Hill: psychedelics.
The proposal would promote research and treatment using psychedelic-assisted therapies specifically for veterans—targeting conditions like PTSD, depression, traumatic brain injury, and substance use.
At the center of it is a plan to create a new Office of Novel Therapeutics within the VA, designed to fast-track research, coordinate studies, and prepare the system for potential rollout if these treatments get federal approval.
And this isn’t fringe anymore.
The bill leans on growing evidence—and growing political support—that substances like psilocybin, MDMA, and ibogaine could play a serious role in mental health treatment, especially for veterans who haven’t responded to traditional options.
What’s interesting is who’s backing it.
This isn’t coming from the usual reform crowd—it’s a GOP-led effort, showing just how bipartisan (and urgent) the conversation around alternative therapies has become.
Because for a lot of veterans, the current system isn’t working.
And Washington is starting to admit it might need to look in some very unconventional places for answers.
Dabbin-Dad Newsroom
